Anti-angiogenic compositions and methods of use

Details for Australian Patent Application No. 2011218716 (hide)

Owner The University of British Columbia Angiotech Pharmaceuticals, Inc.

Inventors Arsenault, Larry A.; Burt, Helen M.; Hunter, William L.; Jackson, John K.; Machan, Lindsay S.

Agent Davies Collison Cave

Pub. Number AU-A-2011218716

Parent 2007254682

Filing date 1 September 2011

Wipo publication date 22 September 2011

International Classifications

A61K 35/32 (2006.01) Medicinal preparations containing material or reaction products thereof with undetermined constitution - Bones

A61F 2/06 (2006.01) Filters - Blood vessels

A61K 31/17 (2006.01) - having the group NC(O)N or NC(S)N, e.g. urea, thiourea, carmustine

A61K 31/203 (2006.01)

A61K 31/337 (2006.01) - having four-membered rings, e.g. taxol

A61K 31/519 (2006.01) - ortho- or peri-condensed with heterocyclic rings

A61K 31/565 (2006.01) - not substituted in position 17 beta by a carbon atom, e.g. oestrane, oestradiol

A61K 31/57 (2006.01) - substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane, progesterone

A61K 38/36 (2006.01) Medicinal preparations containing peptides - Blood coagulation or fibrinolysis factors

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

15 September 2011 Complete Application Filed

22 September 2011 Application Open to Public Inspection

  Published as AU-A-2011218716

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011218717-Systems and Methods For Improving Investment Performance

2011218715-NMR device for detection of analytes involving magnetic particles